APNAR PHARMA Revenue and Competitors
Estimated Revenue & Valuation
- APNAR PHARMA's estimated annual revenue is currently $21.1M per year.
- APNAR PHARMA's estimated revenue per employee is $201,000
Employee Data
- APNAR PHARMA has 105 Employees.
- APNAR PHARMA grew their employee count by 5% last year.
APNAR PHARMA's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy and Quality Officer | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Managing Director | Reveal Email/Phone |
4 | Director Operations | Reveal Email/Phone |
5 | Sales and Business Development | Reveal Email/Phone |
APNAR PHARMA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is APNAR PHARMA?
Apnar Pharma is a privately owned, rapidly growing pharmaceutical company engaged in the acquisition, licensing, development(ANDA), sales, marketing & distribution of generic pharmaceuticals drugs and OTC (over the counter) non-prescription items for U.S. market. In addition to our strategic partnerships, we have a highly experienced team of professionals that specialize in Analytical development & analysis, formulation development, Regulatory affairs, quality control & quality assurance , Manufacturing ,accounting, marketing, Distribution and finance; who all work together to provide quality medicinal products.
keywords:N/AN/A
Total Funding
105
Number of Employees
$21.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $28.9M | 107 | 13% | N/A |
#2 | $47.6M | 119 | 2% | N/A |
#3 | $30.4M | 124 | 9% | N/A |
#4 | $12.5M | 125 | 20% | N/A |
#5 | $37.7M | 130 | 13% | N/A |